ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

Health Disparities Between Minorities Too Large, Shalala Says

March 27, 1998

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

ASCO Updates Guideline On Use Of Tumor Markers

October 27, 2006

With a “B” from USPSTF, Low-Dose CT Screening For Lung Cancer Earns Coverage Under ACA

August 2, 2013

AACR Reschedules Annual Meeting For July 11-14, in Washington, DC

April 25, 2003

New Publications

March 16, 1990